Prognosis and outcome in CDH1-mutant lobular breast cancer.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Journal of Cancer Prevention

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CEJ.0000000000000405PMID 29595757PMCID PMC6716601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of BRCA germline mutations on breast cancer prognosis

  2016cited by this paper
• CDH1 germline mutations and hereditary lobular breast cancer

  2016cited by this paper
• ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast

  2016influential reference
• Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.

  2015cited by this paper
• E-cadherin germline mutation carriers: clinical management and genetic implications

  2014cited by this paper
• CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study

  2013cited by this paper
• Germline CDH1 mutations in bilateral lobular carcinoma in situ

  2013cited by this paper
• Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.

  2013cited by this paper
• Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer.

  2008cited by this paper
• EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.

  2007cited by this paper
• E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells.

  2003cited by this paper
• Familial gastric cancer: overview and guidelines for management*

  1999cited by this paper

• Harnessing agent-based frameworks in CellAgentChat to unravel cell–cell interactions from single-cell and spatial transcriptomics

  2025cites this paper
• BC-predict: mining of signal biomarkers and production of models for early-stage breast cancer subtyping and prognosis

  2025cites this paper
• A Novel Recurrent Neural Network Framework for Prediction and Treatment of Oncogenic Mutation Progression

  2025cites this paper
• Advances in iron oxide nanoparticles for targeted breast cancer therapy: a promising nanomedicine approach

  2025cites this paper
• Genomic landscape of breast cancer in elderly patients

  2025cites this paper
• miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine

  2024cites this paper
• Elacestrant in the treatment landscape of ER-positive, HER2-negative, ESR1-mutated advanced breast cancer: a contemporary narrative review

  2024cites this paper
• Breast cancer prognosis through the use of multi-modal classifiers: current state of the art and the way forward.

  2024cites this paper
• Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania

  2024cites this paper
• Harnessing Agent-Based Modeling in CellAgentChat to Unravel Cell-Cell Interactions from Single-Cell Data

  2024cites this paper
• Preconditioned Chorionic Villus Mesenchymal Stem/Stromal Cells (CVMSCs) Minimize the Invasive Phenotypes of Breast Cancer Cell Line MDA231 In Vitro

  2023influential citation
• Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment

  2023cites this paper
• GSH resistant, luminescent 2-(pyren-1-yl)-1H-imidazo[4,5-f][1,10]phenanthroline-based Ru(II)/Ir(III)/Re(I) complexes for phototoxicity in triple-negative breast cancer cells.

  2023cites this paper
• Epigenetic regulation of breast cancer metastasis

  2023cites this paper
• The Potential of Genetics in Identifying Women at Lower Risk of Breast Cancer

  2023cites this paper
• Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach

  2022cites this paper
• Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence

  2022cites this paper
• PIGNON: a protein–protein interaction-guided functional enrichment analysis for quantitative proteomics

  2021cites this paper
• CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer

  2021cites this paper
• Complete Identification of Autophagy-Related lncRNA Prognostic Signature for Breast Cancer

  2021cites this paper
• Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expression

  2021cites this paper
• Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

  2021cites this paper
• Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expression

  2021cites this paper
• Is cancer biology different in older patients?

  2021cites this paper
• Identification of Pathway-Based Biomarkers with Crosstalk Analysis for Overall Survival Risk Prediction in Breast Cancer

  2021cites this paper
• Genomic Alteration in Metastatic Breast Cancer and Its Treatment.

  2020cites this paper
• Clinical significance of variants of unknown significances in BRCA genes

  2019cites this paper
• Tumor inactivation of E-cadherin: a new tool for breast cancer treatment?

  2018cites this paper
• The Italian Ministry of Health promotes more than 300 research projects to improve cancer prevention, treatment, and prognosis.

  2018cites this paper